Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Trends 2014 - 2020

Transparency Market Research

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Published Date 1-Sep-2014

74 Page Report

Buy Now

Request Sample

Press Release

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates, and Ten Late Stage Candidates: Transparency Market Research

Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market

REPORT DESCRIPTION

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 According to a new market report published by Transparency Market Research "Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" six phase III drugs would generate total revenue of USD 3.8 billion by 2020. Browse the full Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Report at http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html Hospital acquired infections also called as healthcare associated infections or nosocomial infections have raised serious concerns due to multidrug resistance shown by microorganisms. Multidrug resistant organisms are immune to the conventional antibiotics, hence very difficult to treat. Pneumonia accounts for over 22% of all the hospital acquired infections. Since hospital acquired pneumonia is mainly caused as a result of prolonged exposure to ventilator, it is also called as ventilator associated pneumonia. The infection is common in immunocompromised patients,...